New drug trial targets mysterious swelling disease
Disease control
Completed
This study tested whether the drug zanubrutinib could help people with IgG4-related disease, a condition that causes painful swelling in glands like those in the face and eyes. Ten participants took the oral drug twice daily for 24 weeks. The main goal was to see if the treatment…
Phase: PHASE2 • Sponsor: Matthew C. Baker • Aim: Disease control
Last updated Apr 02, 2026 05:41 UTC